Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment

Frontiers in Immunology(2024)10.3389/fimmu.2023.1280205Source: DataRank Database

Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

bioproject brenda doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.06)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Lauren P. Chrisman ORCID,Gail L. Enriquez,Madeline J. Hooper ORCID,Teresa L. Griffin,Merjaan Ahmad

Live enrichment

PubMed:38274799 PMC:PMC10808320 OpenAlex:https://openalex.org/W4390745690

NCATS NIH HHS

Grant: KL2 TR001424

American Cancer Society

Dermatology Foundation

Cutaneous Lymphoma Foundation

National Institutes of Health

FWCI

4.06

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1280205/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1280205/pdf?isPublishedV2=False

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1280205/full

journalhttps://doi.org/10.3389/fimmu.2023.1280205

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38274799

Fields of Study

Cutaneous lymphoproliferative disorders researchDermatology and Skin DiseasesFungal Infections and Studies

MeSH Terms

Gastrointestinal MicrobiomeBacteriaHumansPhylogenyRNA, Ribosomal, 16SSkin NeoplasmsLymphoma, T-Cell, CutaneousDysbiosis

Keywords

MicrobiomeDysbiosisBiologyDiseaseImmunologyGut floraLachnospiraceaeLymphomaMedicineBacteriaInternal medicineGenetics16S ribosomal RNAFirmicutesInositolCancerPhototherapySkin CancerCutaneous T Cell LymphomaGut Dysbiosis

Sustainable Development Goals

SDG 0: Good health and well-being

Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment

FAIR Checklist

Authors (12)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)